CTPS1-IN-1

• UNSPSC Description:

  CTPS1-IN-1 (compound R80) is a CTPS1 inhibitor. CTPS1-IN-1 has the potential to research cancer (such as promoting vascular injury or surgical recovery) and immune system diseases (such as rejection of transplanted cells and tissues, transplant-related diseases or disorders, allergies, and autoimmune diseases)[1].

• Target Antigen:

  DNA/RNA Synthesis

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Cancer; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/ctps1-in-1.html

• Solubility:

  DMSO : 50 mg/mL (ultrasonic;warming;heat to 60°C)

• Smiles:

  O=C(C1=NC=C(C2=CN=CC(OCC)=N2)C=C1)NC3(CC3)C4=CSC(NS(=O)(C5CC5)=O)=N4

• Molecular Weight:

  486.57

• References & Citations:

  [1]Andrew Novak, et al. Preparation of substituted sulfonamidothiazoles as CTRS1 inhibitors. Patent WO2019106146A1.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2341943-12-0